This study has shown significant quantitative differences in the expression of DJ-1, PTEN, and p-Akt amongst the different stages of OSCC development and progression, which paves the way for utilizing these proteins as prognostic biomarkers to predict outcomes and potentially serving as therapeutic targets for patients suffering from oral cancer. This evidence concerns the gene PTEN and lip and oral cavity carcinoma.